ACCESS Intervention for HIV Testing (ACCESS Trial)

Palo Alto (17 mi)

Overseen byTyler Bartholomew, PhD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: N/A

Waitlist Available

Sponsor: University of Miami

No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

Eligibility Criteria

This trial is for people who inject drugs (PWID) and are using syringe services programs (SSPs). It aims to help these individuals get routine testing for HIV and Hepatitis C, as well as support if they test positive. There's no detailed exclusion criteria provided, but typically participants must meet certain health conditions.

Treatment Details

The study is examining the ACCESS strategy, which provides funding and guidance to SSPs to offer regular, automatic HIV and HCV testing with easy access to treatment. The effectiveness of this approach will be compared with a control group not receiving the intervention.

2Treatment groups

Experimental Treatment

Active Control

Group I: ACCESS GroupExperimental Treatment1 Intervention

Participants in this group will receive the ACCESS intervention for up to 18 months

Group II: Control GroupActive Control1 Intervention

Participants in this group will receive a link to the CDC Compendium of Evidence-Based Interventions for up to 18 months.